Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Investments:
Equity securities, at fair value (cost: $1,563 and $1,926)	$ 213	$ 680
Cash and cash equivalents	3,594	495
Restricted cash and cash equivalents	391	3,250
Premiums receivable	2,118	977
Other Investments	965	2,478
Loan Receivable		100
Due from Related Party	63	63
Deferred policy acquisition costs	240	101
Operating lease right-of-use assets	124	9
Prepayment and other assets	113	96
Property and equipment, net	2	4
Total assets	7,823	8,253
Liabilities and Shareholders’ Equity
Notes payable to noteholders	118	118
Notes payable to Epsilon/DeltaCat Re Tokenholders	1,239	1,523
Unearned Premium Reserve	2,181	915
Operating lease liabilities	124	9
Accounts payable and other liabilities	374	356
Total liabilities	4,036	2,921
Shareholders’ equity:
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 6,036,579 and 5,870,234 shares issued and outstanding)	6	6
Additional paid-in capital	32,921	32,740
Accumulated Deficit	(29,140)	(27,414)
Total shareholders’ equity	3,787	5,332
Total liabilities and shareholders’ equity	$ 7,823	$ 8,253